Treatment Guidelines

The International AIDS Society–USA commissions expert panels to issue recommendations and guidelines for patient care in areas where there is controversy or insufficient data for definitive approaches to care or treatment. Funding for the guidelines is provided by the International AIDS Society–USA; commercial support is not accepted. Panel members participate on a volunteer basis.

Previous Journal Bibliography

• Updated Recommendations for the Use of Antiretroviral Therapy
  (JAMA. 1996, 1997, 1998, 2000, 2002, 2004, and 2006)
  2006 Recommendations
  2004 Recommendations
  2002 Recommendations
  2000 Recommendations
  1998 Recommendations
  1997 Recommendations
  1996 Recommendations
  
  
• Recommendations for the Use of HIV Resistance Testing
  (Hirsch MS et al. JAMA. 1998, 2000, and 2003)
  2003 Recommendations
  2000 Recommendations
  1998 Recommendations
  
  
• IAS–USA panel recommendations for the management of metabolic complications in HIV infection were published in the November 1, 2002, issue of JAIDS. Click on the citation below to access the full text version of the paper, provided courtesy of JAIDS.
  
  Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society–USA Panel. (Schambelan M, Benson C, Carr A, et al. J Acquir Immune Defic Syndr. 2002; 31(3) 257-275.) Copyright by Lippincott Williams & Wilkins, reprinted with permission.
  
  
• Use of the Ganciclovir Implant for the Treatment of Cytomegalovirus Retinitis in the Era of Potent Antiretroviral Therapy (Martin DF et al. Am J Ophthalmol. 1999)
  
  
• Recommendations for CMV Treatment (Whitley RJ et al. Arch Intern Med. 1998)
  
  
• Interim Guidelines for the Use of Plasma HIV RNA Assays for Patient Management (Saag MS et al. Nat Med. 1996)